S100A8 and gastric carcinoma: Moreover, our observation in Mongolia, the second highest gastric carcinoma prevalence based on age standardization rate (ASR); GLOBOCAN, 2012 (http://globocan.iarc.fr) (ASR = 47.4/100,000 men), showed our developed East-Asian specific CagA antibody [46] had negative results in most of immunohistochemistry biopsy specimens [43], suggesting the most CagA type in Mongolia was Western type.